Journal
JOURNAL OF ALZHEIMERS DISEASE
Volume 20, Issue 1, Pages 145-157Publisher
IOS PRESS
DOI: 10.3233/JAD-2010-1351
Keywords
Alzheimer's disease; amyloid-beta; apoptosis; hyperphosphorylation; mitochondria; tau
Categories
Funding
- National Natural Science Foundation of China [30772292, 30731160621]
- National Major [2006CB500703]
Ask authors/readers for more resources
It has been a puzzle why the tangle-bearing neurons in Alzheimer's disease (AD) brain do not die preferentially of apoptosis even though they are actually challenged by multiple proapoptotic factors. Recently, we have reported that phosphorylation of tau can antagonize apoptosis induced by exogenous apoptotic inducers. Amyloid-beta (A beta), a recognized endogenous proapoptotic factor, is significantly increased in the AD brains, however, it is not known whether tau could abate the A beta-potentiated apoptosis. Here, we observed that the cells bearing high level of A beta were more vulnerable than the controls to H2O2-induced apoptosis, and this effect of A beta was associated with decrease of Bcl-2, elevation of Bax and cytosolic cytochrome-c, as well as activation of caspase-3, suggesting that A beta could potentiate the oxidant-induced cell apoptosis with involvement of mitochondria-caspase-3 pathway. More importantly, we also found that expression of tau that became hyperphosphorylated could reduce the A beta-potentiated apoptosis with simultaneous preservation of Bcl-2 and suppression of Bax, cytosolic cytochrome-c, and caspase-3 activity, implying that overexpression of tau that became hyperphosphorylated can attenuate the A beta-potentiated cell apoptosis through mitochondria-caspase-3 pathway. These findings provide an explanation of the chronic nature of neurodegeneration of neurons with neurofibrillary pathology of abnormal hyperphosphorylated tau in AD and related tauopathies.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available